Summary of Changes

Attachment C
Paperwork Reduction Act Submission
OMB # 0938 – 0944
CMS-10142
Summary of MA BPT Changes from CY2025 to CY2026
•

Updated Contract Year from CY2025 to CY2026

•

Worksheet 1 – MA BASE PERIOD EXPERIENCE AND PROJECTION
ASSUMPTIONS

•

•

Removed VBID-H indicator on Worksheet 1 Section I (no longer applicable)

•

Added input cell I17 to reflect the certifying actuary’s chosen MA level of
significance when determining what base period data to include for crosswalked
plans

•

Added new Section VI to reflect the break-out of the net PMPM for risk-sharing
arrangement payment adjustments in the base period

Worksheet 3 – MA PROJECTED COST SHARING PMPM
•

•

Updated Section IV Mapping to remove line 19c VBID-H (no longer applicable)

Worksheet 4 – MA PROJECTED REVENUE REQUIREMENT PMPM
•

Added new input cells (U78:U98) to reflect the break-out of the net PMPM for
risk-sharing arrangement payment adjustments in the projection period

•

Added new cell to Section III (J131) allowing plans to indicate whether they want
Total CY ESRD “subsidy” in cell J130 to flow through to MA Worksheet 4,
Section II cell H95

Summary of Part D BPT Changes from CY2024 to CY2025 (Contract
Year Updates and Updates Necessary to reflect Inflation Reduction Act)
•

Updated Contract Year from CY2025 to CY2026

•

Worksheet 1 – Rx BASE PERIOD EXPERIENCE
•

Removed insulins and vaccine lines from Section VI on Worksheet 1. For
CY2026, this would remain grayed out since it is not applicable for CY2024.

•

Added new Section VIII to reflect the dollars associated with DIR #10 in the base
period

Page 1 of 2

•

•

Worksheet 2 – Rx PROJECTION OF ALLOWED/NON-BENEFIT EXPENSES
•

Added new Section VIII to reflect the dollars associated with DIR #10 in the
projection period

•

Activated cells on Worksheet 2 for Maximum Fair Price Drugs projection factors.

Worksheet 3 – Rx CONTRACT PERIOD PROJECTION FOR DEFINED
STANDARD COVERAGE
•

•

Worksheet 6 – Rx Script Projections for Defined Standard, Actuarially Equivalent, or
Alternative Coverage
•

•

Removed insulins and vaccine lines from Section IV on Worksheet 3 and
activated cells for maximum fair price drugs in this section.

Activated and relocated inputs on Worksheet 6 for Subsidy for Selected Drugs.
See cells D59:D60.

Worksheet 7– SUMMARY OF KEY BID ELEMENTS
•

Added payment cell F31 for Selected Drug subsidy which flows from Worksheet
6 inputs

The CY 2026 Draft MA and Part D Bid instructions were updated to reflect the proposed
changes presented on the November 2024 User Group Call and to reflect the BPT
revisions outlined above.
The revisions were necessary for accuracy and/or applicability and to reflect changes
from the Inflation Reduction Act (IRA). The revisions neither increase nor decrease the
burden.

Page 2 of 2